MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617067947 A) filed by Merck Sharp & Dohme LLC on May 30, 2026, for Ripk1 Inhibitors And Methods Of Use.
Inventors include Achab, Abdelghani Abe; Boyko, Yaroslav; Chen, Yi-Heng; Dimauro, Erin F.; Rico Duque, Jenny Lorena; Fradera, Xavier; Palani, Anandan; Pio, Barbara; Rickard, Meredith M.; Siliphaivanh, Phieng; Su, Jing; and Vara, Brandon A..
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: Described herein are compounds of Formula I (I), or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as RIPK1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for RIPK1-related diseases.
Disclaimer: Curated by HT Syndication.
